Evidence map›Paper›PMID 36042309›Full record

ArticleNature neuroscience2022

Experimenters' sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor.

Polymnia Georgiou, Panos Zanos, Ta-Chung M Mou, Xiaoxian An, Danielle M Gerhard, Dilyan I Dryanovski, Liam E Potter, Jaclyn N Highland, Carleigh E Jenne, Brent W Stewart and 12 more

Open access · greenAbstract read
In one paragraph

Article in Nature neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
14.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 131 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A Time-Sensitive Plasticity Distinguishes the Rapid and Sustained Synaptic Actions of Ketamine from Its (2The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Rapid hippocampal synaptic potentiation induced by ketamine metabolite (2R,6R)-hydroxynorketamine persistently primes synaptic plasticity.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 2 countries.

Polymnia GeorgiouVeterans Affairs Maryland Health Care System, Baltimore, MD, USA.
Panos ZanosDepartment of Psychiatry, School of Medicine, University of Maryland, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-1968-8648
Ta-Chung M MouDepartment of Psychiatry, School of Medicine, University of Maryland, Baltimore, MD, USA.
Xiaoxian AnDepartment of Psychiatry, School of Medicine, University of Maryland, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-1739-6342
Danielle M GerhardDepartment of Psychiatry, Yale University, New Haven, CT, USA.
Dilyan I DryanovskiDepartment of Psychiatry, School of Medicine, University of Maryland, Baltimore, MD, USA.
Liam E PotterDepartment of Psychiatry, School of Medicine, University of Maryland, Baltimore, MD, USA.
Jaclyn N HighlandDepartment of Psychiatry, School of Medicine, University of Maryland, Baltimore, MD, USA.
Carleigh E JenneDepartment of Psychiatry, School of Medicine, University of Maryland, Baltimore, MD, USA.
Brent W StewartDepartment of Psychiatry, School of Medicine, University of Maryland, Baltimore, MD, USA.
Katherine J PultorakThe Graduate Program in Neuroscience, University of Maryland, Baltimore, MD, USA.
Peixiong YuanExperimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Chris F PowelsDepartment of Psychiatry, School of Medicine, University of Maryland, Baltimore, MD, USA.ORCID http://orcid.org/0000-0003-2483-6884
Jacqueline LovettBiomedical Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.
Edna F R PereiraDepartment of Epidemiology and Public Health, School of Medicine, University of Maryland, Baltimore, MD, USA.
Sarah M ClarkVeterans Affairs Maryland Health Care System, Baltimore, MD, USA.
Leonardo H TonelliVeterans Affairs Maryland Health Care System, Baltimore, MD, USA.
Ruin MoaddelBiomedical Research Center, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA.
Carlos A ZarateExperimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Ronald S DumanDepartment of Psychiatry, Yale University, New Haven, CT, USA.
Scott M ThompsonDepartment of Psychiatry, School of Medicine, University of Maryland, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-9844-9049
Todd D GouldVeterans Affairs Maryland Health Care System, Baltimore, MD, USA. gouldlab@me.com.ORCID http://orcid.org/0000-0003-1511-7183
University of Maryland, Baltimore · USNational Institutes of Health · USCornell University · USYale University · US

Funding

Therapeutic Efficacy of Ketamine Metabolites for Depression TreatmentR01MH107615 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI GOULD, TODD D · 2016 to 2025
$7.2M
Role of mTOR and Synaptogenesis in the Actions of Rapid-Acting AntidepressantsR01MH093897 · NIMH · YALE UNIVERSITY · PI DILEONE, RALPH J · 2011 to 2021
$5.0M
Stress, Depression, Serotonin, and Plasticity of Excitatory TransmissionR01MH086828 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI THOMPSON, SCOTT M. · 2010 to 2019
$3.8M
Hydroxynorketamine for the Treatment of PTSD and AnhedoniaI01BX004062 · VA · BALTIMORE VA MEDICAL CENTER · PI GOULD, TODD D · 2019 to 2023
–
BLRD VA I01 BX004062Intramural NIH HHS Z99 AG999999NIMH NIH HHS L30 MH091729NIMH NIH HHS R01 MH086828NIMH NIH HHS R01 MH093897NIMH NIH HHS R01 MH107615
6 · The paper itself

Abstract

We show that the sex of human experimenters affects mouse behaviors and responses following administration of the rapid-acting antidepressant ketamine and its bioactive metabolite (2R,6R)-hydroxynorketamine. Mice showed aversion to the scent of male experimenters, preference for the scent of female experimenters and increased stress susceptibility when handled by male experimenters. This human-male-scent-induced aversion and stress susceptibility was mediated by the activation of corticotropin-releasing factor (CRF) neurons in the entorhinal cortex that project to hippocampal area CA1. Exposure to the scent of male experimenters before ketamine administration activated CA1-projecting entorhinal cortex CRF neurons, and activation of this CRF pathway modulated in vivo and in vitro antidepressant-like effects of ketamine. A better understanding of the specific and quantitative contributions of the sex of human experimenters to study outcomes in rodents may improve replicability between studies and, as we have shown, reveal biological and pharmacological mechanisms.

Indexed as

Behavior, AnimalKetamineResearch PersonnelSex CharacteristicsAnimalsAntidepressive AgentsCorticotropin-Releasing HormoneFemaleHippocampusHumansMaleMiceNeuronsAntidepressive AgentsCorticotropin-Releasing HormoneKetamine

Identifiers

PMID36042309
PMCPMC10186684
OpenAlexW4293582084

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.